Find Etiproston manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

US DMFs Filed

0

CEP/COS

CEP/COS Certifications

0

JDMF

JDMFs Filed

0

EU WC

EU WC

0

KDMF

KDMF

0

NDC API

NDC API

0

VMF

NDC API

API REF. PRICE (USD/KG)

$
$ 0

MARKET PLACE

0

API

0

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0

FDF Dossiers

FDF Dossiers

0

FDA Orange Book

FDA (Orange Book)

0

Europe

Europe

0

Canada

Canada

0

Australia

Australia

0

South Africa

South Africa

0

Listed Dossiers

Listed Dossiers

0 DRUGS IN DEVELOPMENT

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

0

Health Canada Patents

DIGITAL CONTENT

0

Data Compilation #PharmaFlow

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

0

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid

NA

Annual Reports

NA

Finished Drug Prices

NA

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set
Also known as: 59619-81-7, Etiprostone, Etiproston [inn], Prostavet, Tcu22w0apy, (z)-7-[(1r,2r,3r,5s)-3,5-dihydroxy-2-[(e)-2-[2-(phenoxymethyl)-1,3-dioxolan-2-yl]ethenyl]cyclopentyl]hept-5-enoic acid
Molecular Formula
C24H32O7
Molecular Weight
432.5  g/mol
InChI Key
BPALXSWPHQNCAA-RLJNYRALSA-N
FDA UNII
TCU22W0APY

Etiproston
1 2D Structure

Etiproston

2 Identification
2.1 Computed Descriptors
2.1.1 IUPAC Name
(Z)-7-[(1R,2R,3R,5S)-3,5-dihydroxy-2-[(E)-2-[2-(phenoxymethyl)-1,3-dioxolan-2-yl]ethenyl]cyclopentyl]hept-5-enoic acid
2.1.2 InChI
InChI=1S/C24H32O7/c25-21-16-22(26)20(19(21)10-6-1-2-7-11-23(27)28)12-13-24(30-14-15-31-24)17-29-18-8-4-3-5-9-18/h1,3-6,8-9,12-13,19-22,25-26H,2,7,10-11,14-17H2,(H,27,28)/b6-1-,13-12+/t19-,20-,21+,22-/m1/s1
2.1.3 InChI Key
BPALXSWPHQNCAA-RLJNYRALSA-N
2.1.4 Canonical SMILES
C1COC(O1)(COC2=CC=CC=C2)C=CC3C(CC(C3CC=CCCCC(=O)O)O)O
2.1.5 Isomeric SMILES
C1COC(O1)(COC2=CC=CC=C2)/C=C/[C@H]3[C@@H](C[C@@H]([C@@H]3C/C=C\CCCC(=O)O)O)O
2.2 Other Identifiers
2.2.1 UNII
TCU22W0APY
2.3 Synonyms
2.3.1 MeSH Synonyms

1. Etiproston Tromethamine

2.3.2 Depositor-Supplied Synonyms

1. 59619-81-7

2. Etiprostone

3. Etiproston [inn]

4. Prostavet

5. Tcu22w0apy

6. (z)-7-[(1r,2r,3r,5s)-3,5-dihydroxy-2-[(e)-2-[2-(phenoxymethyl)-1,3-dioxolan-2-yl]ethenyl]cyclopentyl]hept-5-enoic Acid

7. Etiproston (inn)

8. (z)-7-((1r,2r,3r,5s)-3,5-dihydroxy-2-((e)-2-(2-(phenoxymethyl)-1,3-dioxolan-2-yl)vinyl)cyclopentyl)-5-heptenoic Acid

9. Etiprostonum

10. Etiprostone [inn-french]

11. Unii-tcu22w0apy

12. Etiprostonum [inn-latin]

13. Brn 1274276

14. Etiproston [mi]

15. Prostavet [veterinary] (tn)

16. Chembl2104285

17. Schembl11602088

18. Dtxsid501024232

19. Zinc30691625

20. 15-deoxy-15,15-ethylenedioxy-16-phenoxy-17,18,19,20-tetranor-pgf2-alpha

21. 15-deoxy-15,15-ethylenedioxy-16-phenoxy-17,18,19,20-tetranor-prostaglandin F2-alpha

22. D07932

23. 619e817

24. Q27289904

25. 15-deoxy-15, 15-ethylenedioxy-16-phenoxy-omega-tetranor Pgf-2alpha

26. 5-heptenoic Acid, 7-(3,5-dihydroxy-2-(2-(2-(phenoxymethyl)-1,3-dioxolan-2-yl)ethenyl)cyclopentyl)-, (1r-(1-alpha(z),2-beta(e),3-alpha,5-alpha))-

2.4 Create Date
2005-12-16
3 Chemical and Physical Properties
Molecular Weight 432.5 g/mol
Molecular Formula C24H32O7
XLogP32.1
Hydrogen Bond Donor Count3
Hydrogen Bond Acceptor Count7
Rotatable Bond Count11
Exact Mass432.21480336 g/mol
Monoisotopic Mass432.21480336 g/mol
Topological Polar Surface Area105 Ų
Heavy Atom Count31
Formal Charge0
Complexity605
Isotope Atom Count0
Defined Atom Stereocenter Count4
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count2
Undefined Bond Stereocenter Count0
Covalently Bonded Unit Count1

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty